Renaissance Technologies’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,105
| Closed | -$5.81K | – | 3971 |
|
|
2024
Q4 | $5.81K | Sell |
1,105
-2,195
| -67% | -$11.5K | ﹤0.01% | 3531 |
|
|
2024
Q3 | $47.3K | Sell |
3,300
-3,206
| -49% | -$45.9K | ﹤0.01% | 3350 |
|
|
2024
Q2 | $105K | Buy |
6,506
+436
| +7% | +$7.06K | ﹤0.01% | 3175 |
|
|
2024
Q1 | $614K | Sell |
6,070
-2,731
| -31% | -$276K | ﹤0.01% | 2781 |
|
|
2023
Q4 | $208K | Buy |
8,801
+2,156
| +32% | +$51K | ﹤0.01% | 3121 |
|
|
2023
Q3 | $134K | Sell |
6,645
-1,310
| -16% | -$26.4K | ﹤0.01% | 3184 |
|
|
2023
Q2 | $207K | Sell |
7,955
-1,795
| -18% | -$46.7K | ﹤0.01% | 3293 |
|
|
2023
Q1 | $203K | Buy |
9,750
+700
| +8% | +$14.6K | ﹤0.01% | 3274 |
|
|
2022
Q4 | $185K | Sell |
9,050
-6,385
| -41% | -$131K | ﹤0.01% | 3445 |
|
|
2022
Q3 | $426K | Sell |
15,435
-191
| -1% | -$5.27K | ﹤0.01% | 3022 |
|
|
2022
Q2 | $413K | Buy |
15,626
+8,539
| +120% | +$226K | ﹤0.01% | 3268 |
|
|
2022
Q1 | $567K | Buy |
+7,087
| New | +$567K | ﹤0.01% | 3109 |
|
|
2021
Q4 | – | Sell |
-1,530
| Closed | -$495K | – | 4291 |
|
|
2021
Q3 | $495K | Sell |
1,530
-1,925
| -56% | -$623K | ﹤0.01% | 2897 |
|
|
2021
Q2 | $898K | Buy |
+3,455
| New | +$898K | ﹤0.01% | 2722 |
|